Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitedesignmedix.com
CategoryBioTech
Phone503-688-1941
Employees
Founded2006
DescriptionDrug development company

Offices

Portland, USA
2828 SW Corbett Avenue
Suite 140A
Portland, OR, 97201
USA

People

Funding

TOTAL $11.2M
FUNDING TOTAL $11.2M
Partial Close, 6/2010
$1.18M
Venture Round, 7/2013
$7.06M
Grant, 4/2014
$3M

Tags

DesignMedix

DesignMedix, Inc. develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. Diseases like malaria and diarrhea kill millions of people each year and cause untold suffering. The World Health Organization considers drug-resistance to be one of the top three threats to human health today. From the miracle drugs of almost 100 years ago, we are now facing super bugs that can withstand many of the antibiotics that we have available. Because the regular drugs no longer work, costs are rising with the use of stronger drugs and more people are dying when even the strongest therapies do not kill the resistant pathogens. Using proprietary technology, DesignMedix is developing novel drugs to help efforts to alleviate and eliminate these infections.

Recent Milestones

Videos

Screenshots

DesignMedix screenshot
Above: Homepage
Uploaded: 7/18/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. DesignMedix receives $3 million NIH grant to develop new anti-malarial drug (news-medical.net) [edit]
Edit This Page
Last Edited 4/15/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy